Health Trials

Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation

1

Review clinical trials related to Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

This s a multi-center, open-label phase Ib/II study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of GH21 combined with D-1553 in patients with advanced or metastatic solid tumors harboring KRAS G12C mutation.

Participants needed: 126
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Suzhou Genhouse Bio Co., Ltd.Updated: Jul 8, 2024
Eligibility criteria

The patient or his legal representative is able to understand and voluntarily si... [+4]

acute myocardial infarction, unstable angina pectoris, coronary artery bypass gr... [+5]

Read more